Thursday, October 15, 2026

Silver Futures Bullish Momentum With A 11% Rise In The Last 21 Sessions

ViaNews Editorial Team

October 5, 2024

Silver Futures Bullish Momentum With A 11% Rise In The Last 21 Sessions

(VIANEWS) - Silver (SI) has been up by 11.92% for the last 21 sessions. At 11:51 EST on Saturday, 5 October, Silver (SI) is $32.45.

Volume

Today's last reported volume for Silver is 85593, 99.99% below its average volume of 8862022955.81.

Volatility

Silver's last week, last month's, and last quarter's current intraday variation average was 1.24%, 0.75%, and 1.40%, respectively.

Silver's highest amplitude of average volatility was 1.24% (last week), 1.17% (last month), and 1.40% (last quarter), respectively.

Commodity Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Silver's commodity is considered to be oversold (<=20).

Previous days news about Silver (SI)

  • Silver price forecast: xag/usd depreciates to near $31.50, downside seems limited. According to FXStreet on Thursday, 3 October, "This downside of the Silver price could be attributed to recent strong US labor data, which could increase the odds of the Federal Reserve (Fed) delivering another bumper rate cut in November. ", "However, the downside of safe-haven assets like Silver could be limited following the rising geopolitical tensions in the Middle East. "
  • Silver price forecast: xag/usd stays in tight range near $32 with US NFP under spotlight. According to FXStreet on Friday, 4 October, "In today's session, the major trigger for the Silver price will be the United States (US) Nonfarm Payrolls (NFP) data for September, which will be published at 12:30 GMT. "
  • Gold and silver are max long – TDS. According to FXStreet on Friday, 4 October, "Conversely, Silver prices have a smaller margin of safety against the first selling program, but in the event that nascent signs of reflationary trends persist, Silver andbase metalsare a superior expression."

More news about Silver (SI).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com